Neuromuscular Junction Diseases

Diseases of the neuromuscular junction cause skeletal muscle fatigue and include inherited and acquired disorders that affect presynaptic, intrasynaptic or postsynaptic components. Discover the latest research on neuromuscular junction diseases here.

August 1, 2020
Review
Open Access

A Practical Approach to Managing Patients With Myasthenia Gravis-Opinions and a Review of the Literature

Frontiers in Neurology
Maria Elena Farrugia, John A Goodfellow
July 25, 2020
Review

Congenital Myasthenic Syndromes

Neurologic Clinics
Stanley Jones P Iyadurai
July 28, 2020
Review

Snake three-finger α-neurotoxins and nicotinic acetylcholine receptors: molecules, mechanisms and medicine

Biochemical Pharmacology
Selvanayagam Nirthanan
July 30, 2020
Open Access

miR-9-3p inhibits glioma cell proliferation and apoptosis by directly targeting FOXG1

Oncology Letters
Jianwen ZhenXiaopeng Tong
July 28, 2020
Case Report
Open Access

De novo thymic carcinoma or malignant transformation: a myasthenic patient presented with multiple mediastinal tumours

Respirology Case Reports
Chu-Pin PaiBiing-Shiun Huang
July 25, 2020
Review

Therapeutic and Diagnostic Challenges in Myasthenia Gravis

Neurologic Clinics
Thy NguyenKazim Sheikh
July 21, 2020
Case Report
Open Access

Pembrolizumab-Induced Ocular Myasthenic Crisis

Curēus
Christian J LorenzoNatalia Lattanzio
August 1, 2020

Facial nerve repair by muscle-vein conduit in rats: functional recovery and muscle reinnervation

Tissue Engineering. Part a
Maria Eleni ManthouDoychin Angelov
July 25, 2020
Open Access

Developmental demands contribute to early neuromuscular degeneration in CMT2D mice

Cell Death & Disease
James N SleighGiampietro Schiavo
July 29, 2020
Review

Fatigue in patients with myasthenia gravis. A systematic review of the literature

Neuromuscular Disorders : NMD
Annabel M RuiterMartijn R Tannemaat
July 31, 2020
Open Access

Description of 3 patients with myasthenia gravis and COVID-19

Journal of the Neurological Sciences
Netaniel ReinMarc Gotkine
July 31, 2020

Variants in SCAF4 Cause a Neurodevelopmental Disorder and Are Associated with Impaired mRNA Processing

American Journal of Human Genetics
Anna FliednerChristiane Zweier
July 30, 2020

The Development of PRIMA - A Belgian Prediction Model for Patient Encounters at Mass Gatherings

Prehospital and Disaster Medicine
Kris SpaepenIves Hubloue
July 23, 2020

Case Report: A Rare Case of Silent Sinus Syndrome and Vertical Diplopia

Optometry and Vision Science : Official Publication of the American Academy of Optometry
Joan K Le
July 27, 2020
Open Access

Tolosa-Hunt syndrome with general myasthenia gravis involvement

Journal of Integrative Neuroscience
Lu LiMing-Ou Lu
July 24, 2020

Multiomics data reveals the influences of myasthenia gravis on thymoma and its precision treatment

Journal of Cellular Physiology
Xinjia RuanFei Wang

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Antisense Oligonucleotide - Therapies For ALS

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

© 2020 Meta ULC. All rights reserved
/feed-previews/neuromuscular-junction-diseases/96eef402-05f4-49bd-aa1d-7fce351f28d0